Dr. Jennifer Johnson received an R01 award

Dr. Jennifer Johnson received an R01 award from the National Institute of Mental Health her project titled: THE ROSE SUSTAINMENT (ROSES) STUDY

Dr. Amanda Patterson was awarded the SRI and Bayer Discovery/Innovation Grant

Dr. Amanda Patterson was awarded the SRI and Bayer Discovery/Innovation Grant from the Society for Reproductive Investigation and Bayer for her project titled: The Role of Periostin in Uterine Fibroid Pathogenesis

SIGNATURE CHEFS AUCTION TO HONOR PROMINENT LOCAL RESEARCHER

roman

GRAND RAPIDS, MICHIGAN - 1 in 10 babies are born prematurely in Michigan, putting them at risk of death or lifelong disability. Dr. Lee Anne Roman has dedicated her professional career to help improve those statistics by focusing her research on the under served in an effort to improve socioeconomic and racial/ethnic disparities in maternal and child health outcomes. Dr. Roman is this year’s 2017 Impact Award Recipient and will receive her award at this year’s Signature Chefs Auction.

Read Full Article

Dr. Niraj Joshi received an SRI and Bayer Discovery/Innovation Grant

Dr. Niraj Joshi received an SRI and Bayer Discovery/Innovation Grant from the Society for Reproductive Investigation and Bayer for his project titled: Therapeutic Targeting of Endometriotic Lesions by NOTCH Inhibition

An evening of culinary excellence Signature Chefs Auction, Grand Rapids

DATE: Monday, November 6, 2017 | Time: 5:30 PM
LOCATION: DeVos Place
ADDRESS: 303 Monroe Avenue NW, Grand Rapids, MI 49503

Join us for our annual gathering of West Michigan’s finest culinary talent in support of the March of Dimes. Held in the Steelcase Ballroom at DeVos Place, you will enjoy tasting the signature dishes of local chefs before taking your seats for the Live Auction and Fund the Mission. We encourage you to bid on one of our unique packages. Raise your paddle and give generously to save babies!

Full Event Details

 

grand rapids

Dr. Cristian Meghea received an R21 award

Cris Meghea received an R21 award from the NIH Fogarty International Center and National Cancer Institute for his project titled: MOBILE HEALTH INTERVENTION FOR FAMILY SMOKING CESSATION IN ROMANIA. This two-year award was issued December 2017. The objectives of this project are to determine in a randomized controlled pilot trial (RCT) whether a mHealth couples intervention shows promise in increasing smoking cessation among pregnant couples who smoke and to build mHealth research capacity in Romania. The project builds on his ongoing NIH-funded Quit Together (Renunt in Doi) pregnancy smoking cessation counseling intervention, a US-Romania partnership, and his mHealth intervention to prevent postnatal smoking relapse, a US-Romania-Belgium partnership.

$162,000 postdoctoral fellowship from the American Cancer Society.

Mike Wilson, PhD, a Department of Obstetrics, Gynecology and Reproductive Biology postdoc in Dr. Ronald Chandler's lab, has been awarded a three-year, $162,000 postdoctoral fellowship from the American Cancer Society. The grant is to start January 1, 2018. Congratulations Mike on this very prestigious award!

Asgi Fazleabas - University Distinguished Professor

Asgi Fazleabas, Professor and Associate Chair for Research, Department of Obstetrics, Gynecology & Reproductive Biology, College of Human Medicine, named University Distinguished Professor in 2017. This recognition is among the highest honors that can be bestowed on a faculty member at Michigan State University.

Tae Hoon Kim, Ph.D. - Recipient of the M. D. Anderson Cancer Center Gynecologic SPORE for Uterine Cancer Career Enhancement Program

th kimEndometrial cancer is the most frequently diagnosed malignancy of the female genital tract in the United States. Hysterectomy is typically the first line therapeutic strategy for endometrial cancer. However, there is an increasing demand for non-surgical treatments for endometrial cancer, especially for women who may encounter surgical complications as well as patients with advanced and recurrent endometrial cancer. The current alternative to surgical management of early stage endometrial neoplasia (complex hyperplasia with atypia and grade 1 cancer) is progesterone (P4) treatment, commonly via the Levonorgestrel-Releasing Intrauterine System (Mirena IUD). However, a number of women have P4 refractory disease. Resistance to P4 treatment is the major hurdle of endometrial cancer. Therefore, identifying the molecular mechanisms of P4-resistance, with the goal of identifying alternative targets for non-surgical therapies is important.